Notably, the frequency of the CYP2C9*3 heterozygous genotype (Ht *1/*3) was significantly higher in all groups of patients than in controls and in the group of FM/CFS patients compared with MCS one. The gene discussed is CYP2C9; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.